Phenomena and pathological significances of the methylated p16 promotor in DNA derived from plasma and blood cells of patients with systemic lupus erythematosus

Acta Academiae Medicinae Sinicae

Volumn 28, Issue 5, 2006, Pages 675-681

  Li, An Sheng ^a   Li, Yu Mei ^a   Yang, Ai Zhen ^a,b   Yao, Xu ^a   Chen, Zhi Qiang ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b The 81st Hospital of PLA   (China)

Author keywords

Methylation; p16 gene; Systemic lupus erythematosus

Indexed keywords

DNA; PROTEIN P16;

ALOPECIA; ARTHRITIS; ARTICLE; BLOOD CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA DETERMINATION; FEVER; HUMAN; HUMAN CELL; LABORATORY TEST; MYOSITIS; PATHOGENESIS; PATHOPHYSIOLOGY; PHOTOSENSITIVITY; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN METHYLATION; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ADULT; DNA METHYLATION; FEMALE; GENES, P16; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS);

EID: 37849189762     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Rioux JD, Abbas AK. Paths to understanding the genetic basis of autoimmune disease. Nature, 2005, 435(2):584-589.
2. Fathman CG, Soares L, Chan SM, et al. An array of possibilities for the study of autoimmunity. Nature, 2005, 435 (2):605-611.
3. Peters AH, Schubeler D. Methylation of histones: playing memory with DNA. Curr Opin Cell Biol, 2005, 17(3):341.
4. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature Genetics, 2003, 33:245-254.
5. Januchowski R, Prokop J, Jagodzinski PP. Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. J Appl Genet, 2004, 45(2):237-248.
6. Lind GE, Thorstensen L, Løvig T, et al. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer, 2004, 3(28):1476-4598-3-28.
7. Jen J, Wu L, Sidransky D. An overview on the isolation and analysis of circulating tumor DNA in plasma and serum. Ann N Y Acad Sci, 2000, 906:8-12.
8. Goessl C. Diagnostic potential of circulating nucleic acids for oncology. Expert Rev Mol Diagn., 2003, 3(4):431-442.
9. Wong BCK, Lo YMD. Cell-free DNA and RNA in plasma as new tools for molecular diagnostics. Exp Rev Molecul Diagn, 2003, 3(6):785-797.
10. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 1982, 25:1271-1277.
11. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35:630-640.
12. Herman JG, Graff JR, MyöhÄnen S, et al. Mathylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 1996, 93:9821-9826.
13. Novik KL, Nimmrich I, Genc B, et al. Epigenomics: genome-wide study of methylation phenomena. Curr Issues Mol Biol, 2002, 4(4):111-128.
14. Taback B, Hoon DS. Circulating nucleic acids in plasma and serum: past, present and future. Curr Opin Mol Ther, 2004, 6(3):273-278.
15. Raptis L, Menard HA. Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Invest, 1980, 66:1391-1399.
16. Krieg AM. CpG DNA: a pathogenic factor in systemic lupus erythematosus? J Clin Immunol, 1995, 15:6284-6292.
17. Sato Y, Miyata M, Nishimaki T, et al. CpG motif-containing DNA fragments from sera of patients with systemic lupus erythematosus proliferate mononuclear cells in vitro. J Rheumatol, 1999, 26:294-301.
18. Zeuner RA, Klinman DM, Illei G, et al. Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotides. Rheumatology, 2003, 42:563-569.